BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6861867)

  • 1. Pharmacokinetics of sotalol during pregnancy.
    O'Hare MF; Leahey W; Murnaghan GA; McDevitt DG
    Eur J Clin Pharmacol; 1983; 24(4):521-4. PubMed ID: 6861867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of propranolol during pregnancy.
    O'Hare MF; Kinney CD; Murnaghan GA; McDevitt DG
    Eur J Clin Pharmacol; 1984; 27(5):583-7. PubMed ID: 6519163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single- and multiple-dose pharmacokinetics of sotalol hydrochloride in healthy cats.
    Salmon SJ; Coleman AE; Lynn CR; Sanders JE; Messenger KM
    J Vet Cardiol; 2024 Feb; 51():86-96. PubMed ID: 38118234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on the pharmacokinetics and effects of beta-adrenergic blocking agents, sotalol (author's transl)].
    Tawara K
    Hokkaido Igaku Zasshi; 1977 May; 52(3):245-59. PubMed ID: 914235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oral charcoal and urine pH on sotalol pharmacokinetics.
    Kärkkäinen S; Neuvonen PJ
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):441-6. PubMed ID: 6092287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics of d-sotalol and d,l-sotalol in healthy volunteers.
    Poirier JM; Jaillon P; Lecocq B; Lecocq V; Ferry A; Cheymol G
    Eur J Clin Pharmacol; 1990; 38(6):579-82. PubMed ID: 2373132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of propranolol and sotalol in hyperthyroidism.
    Aro A; Anttila M; Korhonen T; Sundquist H
    Eur J Clin Pharmacol; 1982; 21(5):373-7. PubMed ID: 7075642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sotalol kinetics in renal insufficiency.
    Blair AD; Burgess ED; Maxwell BM; Cutler RE
    Clin Pharmacol Ther; 1981 Apr; 29(4):457-63. PubMed ID: 7471612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the pharmacokinetics and pharmacodynamics of the beta-adrenergic blocking agent sotalol in normal man.
    Schnelle K; Klein G; Schinz A
    J Clin Pharmacol; 1979; 19(8-9 Pt 2):516-22. PubMed ID: 489770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of end-stage renal failure and haemodialysis on the elimination kinetics of sotalol.
    Tjandramaga TB; Verbeeck R; Thomas J; Verbesselt R; Verberckmoes R; Schepper PJ
    Br J Clin Pharmacol; 1976 Apr; 3(2):259-65. PubMed ID: 973960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of (+/-)-sotalol in healthy male volunteers.
    Kimura M; Umemura K; Ikeda Y; Kosuge K; Mizuno A; Nakanomyo H; Ohashi K; Nakashima M
    Br J Clin Pharmacol; 1996 Nov; 42(5):583-8. PubMed ID: 8951189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human pharmacokinetics of sotalol.
    Anttila M; Arstila M; Pfeffer M; Tikkanen R; Vallinkoski V; Sundquist H
    Acta Pharmacol Toxicol (Copenh); 1976 Jul; 39(1):118-28. PubMed ID: 988964
    [No Abstract]   [Full Text] [Related]  

  • 13. The absolute oral bioavailability and population-based pharmacokinetic modelling of a novel dipeptidylpeptidase-IV inhibitor, vildagliptin, in healthy volunteers.
    He YL; Sadler BM; Sabo R; Balez S; Wang Y; Campestrini J; Laurent A; Ligueros-Saylan M; Howard D
    Clin Pharmacokinet; 2007; 46(9):787-802. PubMed ID: 17713976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of sotalol.
    Hanyok JJ
    Am J Cardiol; 1993 Aug; 72(4):19A-26A. PubMed ID: 8346722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of intravenously and orally administered sotalol hydrochloride in horses and effects on surface electrocardiogram and left ventricular systolic function.
    Broux B; De Clercq D; Decloedt A; De Baere S; Devreese M; Van Der Vekens N; Ven S; Croubels S; van Loon G
    Vet J; 2016 Feb; 208():60-4. PubMed ID: 26670333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of intravenous and oral enoxacin in healthy volunteers.
    Chang T; Black A; Dunky A; Wolf R; Sedman A; Latts J; Welling PG
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():49-56. PubMed ID: 3162901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between pharmacokinetics and pharmacodynamics of the beta adrenergic blocking drug sotalol in dogs.
    Ishizaki T; Tawara K
    J Pharmacol Exp Ther; 1979 Nov; 211(2):331-7. PubMed ID: 501565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of food, food constituents and fluid volume on the bioavailability of sotalol.
    Kahela P; Anttila M; Tikkanen R; Sundquist H
    Acta Pharmacol Toxicol (Copenh); 1979 Jan; 44(1):7-12. PubMed ID: 367055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imipramine disposition in users of oral contraceptive steroids.
    Abernethy DR; Greenblatt DJ; Shader RI
    Clin Pharmacol Ther; 1984 Jun; 35(6):792-7. PubMed ID: 6734030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption kinetics of oral sotalol combined with cisapride and sublingual sotalol in healthy subjects.
    Deneer VH; Lie-A-Huen L; Kingma JH; Proost JH; Kelder JC; Brouwers JR
    Br J Clin Pharmacol; 1998 May; 45(5):485-90. PubMed ID: 9643622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.